Healthcare -
Medical - Healthcare Plans - NYSE - US
$ 423.14
-1.34 %
$ 96.2 B
Market Cap
16.47
P/E
1. INTRINSIC VALUE
Balance Sheet
Elevance Health Inc.
| Current Assets | 52.6 B |
| Cash & Short-Term Investments | 33.5 B |
| Receivables | 19.1 B |
| Other Current Assets | 0 |
| Non-Current Assets | 64.3 B |
| Long-Term Investments | -25.2 B |
| PP&E | 4.65 B |
| Other Non-Current Assets | 84.9 B |
| Current Liabilities | 26.2 B |
| Accounts Payable | 22.7 B |
| Short-Term Debt | 2.01 B |
| Other Current Liabilities | 1.51 B |
| Non-Current Liabilities | 49.3 B |
| Long-Term Debt | 29.2 B |
| Other Non-Current Liabilities | 20 B |
EFFICIENCY
Earnings Waterfall
Elevance Health Inc.
| Revenue | 177 B |
| Cost Of Revenue | 19.8 B |
| Gross Profit | 157 B |
| Operating Expenses | 20 B |
| Operating Income | 137 B |
| Other Expenses | 131 B |
| Net Income | 5.97 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Elevance Health Inc.
| Net Income | 5.97 B |
| Depreciation & Amortization | 1.39 B |
| Capital Expenditures | -1.26 B |
| Stock-Based Compensation | 191 M |
| Change in Working Capital | -1.72 B |
| Others | -1.48 B |
| Free Cash Flow | 4.55 B |
Wall Street Analysts Price Targets
Elevance Health Inc.
Wall Street analysts predict an average 1-year price target for ELV of $565 , with forecasts ranging from
a
low of
$478 to a high of $649 .
ELV Lowest Price Target
Wall Street Target
478 USD
12.96%
ELV Average Price Target
Wall Street Target
565 USD
33.50%
ELV Highest Price Target
Wall Street Target
649 USD
53.38%
4. DIVIDEND
ANALYSIS
0.44%
DIVIDEND YIELD
1.71 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Elevance Health Inc.
Sold
0-3 MONTHS
1.57 M USD 2
3-6 MONTHS
3.21 M USD 1
6-9 MONTHS
17.6 M USD 3
9-12 MONTHS
10.8 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
zacks.com
- 2 weeks ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
zacks.com
- 2 weeks ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
zacks.com
- 2 weeks ago
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code - 3972058 (Domestic) 312-470-0178 – Access Code - 3972058 (International) 800-39.
businesswire.com
- 2 weeks ago
Which Healthcare Stock Is the Best Buy Right Now?
In the world of upstart pharmaceuticals and healthcare companies, timing is everything. These firms often struggle for an extended period of time before becoming profitable, but when they see success with a new product—or even clinical trial results suggesting a new product could be on the horizon—they can experience huge rallies in a very short period of time.
marketbeat.com
- 2 weeks ago
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
With a strengthening commercial business, ELV is seeing steady membership growth.
zacks.com
- 1 month ago
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key factors influencing ELV's future growth and efficiency improvements.
seekingalpha.com
- 1 month ago
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
zacks.com
- 1 month ago
54 Upcoming Dividend Increases, Including A King
This week features the largest list of dividend increases ever, with 50 companies, including Coca-Cola extending its 63-year streak with a 5.2% increase. My strategy focuses on companies with consistent dividend growth and outperforming benchmarks, using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ. I recommend the Schwab U.S. Dividend Equity ETF for broad U.S. equity exposure and the Cohen & Steers REIT & Preferred Income Fund for REITs.
seekingalpha.com
- 1 month ago
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last article, in this update, I give three reasons why I feel comfortable taking a contrarian position with ELV stock. Given that Elevance is in financially very healthy shape and is strongly profitable, there is obviously a large margin of safety from an operational perspective.
seekingalpha.com
- 1 month ago
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact profits.
seekingalpha.com
- 1 month ago
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.
seekingalpha.com
- 1 month ago
8. Profile
Summary
Elevance Health Inc. ELV
COUNTRY
US
INDUSTRY
Medical - Healthcare Plans
MARKET CAP
$ 96.2 B
Dividend Yield
0.44%
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Contact
220 Virginia Avenue, Indianapolis, IN, 46204
https://www.elevancehealth.com
IPO
Date
Oct. 30, 2001
Employees
104200
Officers
Ms. Felicia Farr Norwood
Executive Vice President & President of Government Health Benefits
Dr. Udi Manber Ph.D.
Chief Artificial Intelligence Officer
Mr. Mark Bradley Kaye
Executive Vice President & Chief Financial Officer
Mr. Scott Wayne Anglin
SVice President, Treasurer & Chief Investment Officer
Mr. Ronald William Penczek
Senior Vice President, Controller & Chief Accounting Officer
Mr. Scott William Towers
President of Dental Business
Chris Rigg
SVice President & Chief Financial Officer of Anthem's Commercial and Specialty Business Division
Ms. Beth Keyser Chesmha
President of Anthem Blue Cross & Blue Shield in Indiana
Dr. Shantanu Agrawal M.D.
Chief Health Officer
Ms. Gail Koziara Boudreaux
President, Chief Executive Officer & Director